Clinical Trial Update: Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update investigating metoprolol for treating cytokine release syndrome in patients receiving CAR-T therapy, across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematological Malignancy
• Solid Tumor

Drugs mentioned

• METOPROLOL (METOPROLOL TARTRATE)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Solid Tumor, Hematological Malignancy | Phase 1, Phase 2 | Status: UNKNOWN